Product References
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma.
iScience
Shi X,Ding J,Zheng Y,Wang J,Sobhani N,Neeli P,Wang G,Zheng J,Chai D
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Fri Mar 17 00:00:00 UTC 2023
Complete Freund's Adjuvant Induces a Fibroblast-like Synoviocytes (FLS) Metabolic and Migratory Phenotype in Resident Fibroblasts of the Inoculated Footpad at the Earliest Stage of Adjuvant-Induced Arthritis.
Cells
González-Chávez SA,Chaparro-Barrera E,Alvarado-Jáquez MF,Cuevas-Martínez R,Ochoa-Albíztegui RE,Pacheco-Tena C
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Wed Mar 08 00:00:00 UTC 2023
Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth.
Oncogene
Jin Y,Pan Y,Zheng S,Liu Y,Xu J,Peng Y,Zhang Z,Wang Y,Xiong Y,Xu L,Mu K,Chen S,Zheng F,Yuan Y,Fu J
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Tue Mar 01 00:00:00 UTC 2022
An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer.
Frontiers in immunology
Wang KW,Wang MD,Li ZX,Hu BS,Wu JJ,Yuan ZD,Wu XL,Yuan QF,Yuan FL
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Tue Nov 01 00:00:00 UTC 2022
Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression.
Scientific reports
Starikova AV,Skopenkova VV,Polikarpova AV,Reshetov DA,Vassilieva SG,Velyaev OA,Shmidt AA,Savchenko IM,Soldatov VO,Egorova TV,Bardina MV
42-0081-82 was used in Immunohistochemistry to investigate codon optimised gene therapies in alleviating side effects for future treatments.
Mon Jan 17 00:00:00 UTC 2022
Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression.
Scientific reports
Starikova AV,Skopenkova VV,Polikarpova AV,Reshetov DA,Vassilieva SG,Velyaev OA,Shmidt AA,Savchenko IM,Soldatov VO,Egorova TV,Bardina MV
42-0081-82 was used in Immunohistochemistry to investigate codon optimised gene therapies in alleviating side effects for future treatments.
Mon Jan 17 00:00:00 UTC 2022
A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.
Frontiers in immunology
Wang Y,Gu T,Tian X,Li W,Zhao R,Yang W,Gao Q,Li T,Shim JH,Zhang C,Liu K,Lee MH
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Wed Sep 29 00:00:00 UTC 2021
A Cu9S5 nanoparticle-based CpG delivery system for synergistic photothermal-, photodynamic- and immunotherapy.
Communications biology
Zhou L,Chen L,Hu X,Lu Y,Liu W,Sun Y,Yao T,Dong C,Shi S
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Fri Jul 03 00:00:00 UTC 2020
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma.
Nature communications
Galvani E,Mundra PA,Valpione S,Garcia-Martinez P,Smith M,Greenall J,Thakur R,Helmink B,Andrews MC,Boon L,Chester C,Gremel G,Hogan K,Mandal A,Zeng K,Banyard A,Ashton G,Cook M,Lorigan P,Wargo JA,Dhomen N,Marais R
42-0081-82 was used in Immunohistochemistry to show the genetic and phenotypic changes induced by treatment with programmed cell death-1 (PD-1) blockade in a genetically engineered mouse model of melanoma driven by oncogenic BRAF.
Wed Feb 12 00:00:00 UTC 2020
NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer.
Nature communications
Qin G,Wang X,Ye S,Li Y,Chen M,Wang S,Qin T,Zhang C,Li Y,Long Q,Hu H,Shi D,Li J,Zhang K,Zhai Q,Tang Y,Kang T,Lan P,Xie F,Lu J,Deng W
42-0081-82 was used in Immunocytochemistry to verify that triple-negative breast cancer (TNBC) has higher PD-L1 expression than other subtypes.
Fri Apr 03 00:00:00 UTC 2020
Hemozoin produced by mammals confers heme tolerance.
eLife
Pek RH,Yuan X,Rietzschel N,Zhang J,Jackson L,Nishibori E,Ribeiro A,Simmons W,Jagadeesh J,Sugimoto H,Alam MZ,Garrett L,Haldar M,Ralle M,Phillips JD,Bodine DM,Hamza I
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Western Blot
Tue Oct 01 00:00:00 UTC 2019
Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion.
Nature communications
Sun C,Lan P,Han Q,Huang M,Zhang Z,Xu G,Song J,Wang J,Wei H,Zhang J,Sun R,Zhang C,Tian Z
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunofluorescence
Wed Mar 28 00:00:00 UTC 2018
Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis.
Scientific reports
Saranchova I,Han J,Zaman R,Arora H,Huang H,Fenninger F,Choi KB,Munro L,Pfeifer CG,Welch I,Takei F,Jefferies WA
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Tue Feb 13 00:00:00 UTC 2018
The inflammatory phase of fracture healing is influenced by oestrogen status in mice.
European journal of medical research
Haffner-Luntzer M,Fischer V,Prystaz K,Liedert A,Ignatius A
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunofluorescence
Thu Jul 06 00:00:00 UTC 2017
Adeno-associated virus serotype rh.10 displays strong muscle tropism following intraperitoneal delivery.
Scientific reports
Ai J,Li J,Gessler DJ,Su Q,Wei Q,Li H,Gao G
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunofluorescence
Mon Jan 09 00:00:00 UTC 2017
Metabolic maintenance of cell asymmetry following division in activated T lymphocytes.
Nature
Verbist KC,Guy CS,Milasta S,Liedmann S,Kamiński MM,Wang R,Green DR
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunofluorescence
Thu Apr 21 00:00:00 UTC 2016
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33.
Scientific reports
Saranchova I,Han J,Huang H,Fenninger F,Choi KB,Munro L,Pfeifer C,Welch I,Wyatt AW,Fazli L,Gleave ME,Jefferies WA
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Tue Sep 13 00:00:00 UTC 2016
MHC-I and PirB Upregulation in the Central and Peripheral Nervous System following Sciatic Nerve Injury.
PloS one
Bombeiro AL,Thomé R,Oliveira Nunes SL,Monteiro Moreira B,Verinaud L,Oliveira AL
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunofluorescence
Wed Jul 26 00:00:00 UTC 2017
Postsynaptic SDC2 induces transsynaptic signaling via FGF22 for bidirectional synaptic formation.
Scientific reports
Hu HT,Umemori H,Hsueh YP
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunoprecipitation
Thu Sep 15 00:00:00 UTC 2016
CD31 signals confer immune privilege to the vascular endothelium.
Proceedings of the National Academy of Sciences of the United States of America
Cheung K,Ma L,Wang G,Coe D,Ferro R,Falasca M,Buckley CD,Mauro C,Marelli-Berg FM
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Tue Oct 27 00:00:00 UTC 2015
Imaging Tolerance Induction in the Classic Medawar Neonatal Mouse Model: Active Roles of Multiple F1-Donor Cell Types.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Bascom RA,Tao KS,Tollenaar SL,West LJ
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunocytochemistry
Tue Sep 01 00:00:00 UTC 2015
T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue.
Journal of immunology (Baltimore, Md. : 1950)
Lebrun A,Portocarrero C,Kean RB,Barkhouse DA,Faber M,Hooper DC
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunofluorescence
Sun Nov 01 00:00:00 UTC 2015
MFG-E8 Is Critical for Embryonic Stem Cell-Mediated T Cell Immunomodulation.
Stem cell reports
Tan Y,AlKhamees B,Jia D,Li L,Couture JF,Figeys D,Jinushi M,Wang L
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunofluorescence
Tue Nov 10 00:00:00 UTC 2015
Use of tilapia piscidin 3 (TP3) to protect against MRSA infection in mice with skin injuries.
Oncotarget
Huang HN,Chan YL,Hui CF,Wu JL,Wu CJ,Chen JY
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunohistochemistry
Sat May 30 00:00:00 UTC 2015
Adjuvant cationic liposomes presenting MPL and IL-12 induce cell death, suppress tumor growth, and alter the cellular phenotype of tumors in a murine model of breast cancer.
Molecular pharmaceutics
Meraz IM,Savage DJ,Segura-Ibarra V,Li J,Rhudy J,Gu J,Serda RE
42-0081 was used in Immunohistochemistry to show how combination liposomal therapy was able to induce similar reductions in tumor growth in both treated and distal tumors, suggesting a systemic immune response.
Mon Oct 06 00:00:00 UTC 2014
Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice.
Cardiovascular research
Wan W,Lionakis MS,Liu Q,Roffê E,Murphy PM
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Western Blot
Fri Mar 01 00:00:00 UTC 2013
In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice.
PloS one
Cabrera M,Pewe LL,Harty JT,Frevert U
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunofluorescence
Tue Mar 18 00:00:00 UTC 2014
A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.
PloS one
Schuster C,Brosi H,Stifter K,Boehm BO,Schirmbeck R
Published figure using CD8a monoclonal antibody (Product # 42-0081-82) in Immunofluorescence
Tue Apr 08 00:00:00 UTC 2014
Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
Investigative ophthalmology & visual science
Mochimaru H,Usui T,Yaguchi T,Nagahama Y,Hasegawa G,Usui Y,Shimmura S,Tsubota K,Amano S,Kawakami Y,Ishida S
Thu May 01 00:00:00 UTC 2008
Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes.
Circulation
Yang Z,Day YJ,Toufektsian MC,Xu Y,Ramos SI,Marshall MA,French BA,Linden J
Tue Nov 07 00:00:00 UTC 2006